GENETICO PJSC Past Earnings Performance
Past criteria checks 0/6
There is insufficient data on GENETICO PJSC's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Healthcare Industry Growth | 13.4% |
| Revenue growth rate | n/a |
| Return on equity | n/a |
| Net Margin | n/a |
| Last Earnings Update | 30 Sep 2021 |
Recent past performance updates
No updates
Recent updates
No updates
Revenue & Expenses BreakdownBeta
How GENETICO PJSC makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 21 | 407 | -116 | 136 | 0 |
| 31 Mar 21 | 368 | -97 | 112 | 0 |
| 31 Dec 20 | 360 | -49 | 105 | 0 |
| 30 Sep 20 | 357 | 1 | 87 | 0 |
| 31 Mar 20 | 406 | 92 | 53 | 0 |
| 31 Dec 19 | 400 | 69 | 37 | 0 |
| 31 Dec 18 | 328 | 62 | 14 | 0 |
| 31 Dec 17 | 214 | -45 | 17 | 0 |
Quality Earnings: Insufficient data to determine if GECO has high quality earnings.
Growing Profit Margin: Insufficient data to determine if GECO's profit margins have improved over the past year.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if GECO's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare GECO's past year earnings growth to its 5-year average.
Earnings vs Industry: Insufficient data to determine if GECO's earnings growth over the past year exceeded the Healthcare industry average.
Return on Equity
High ROE: GECO has a negative Return on Equity (0%), as it is currently unprofitable.